We can hope, though, that the manufacturer has put more thought into patient safety with ceramic hips than it allegedly did with metal-on-metal hips.
(PRWEB) April 25, 2013
As the company faces thousands of DePuy ASR lawsuits across the nation, Johnson & Johnson subsidiary DePuy received FDA approval of its premarket approval application supplement in April 2013 for a ceramic-on-ceramic total hip replacement system. The Rottenstein Law Group, a DePuy ASR law firm, notes that this all-ceramic system differs from the metal-on-metal ASR. The firm maintains a page on its website with news and information about DePuy lawsuits.
According to the FDA Approval Order,* dated April 2, 2013, the DePuy Ceramax Ceramic Total Hip System is intended to be used on older patients whose hips are damaged because of noninflammatory degenerative joint disease. Unlike the ASR, the Ceramax is not a metal-on-metal system, which has been known to carry with it the risk of metal components rubbing together with the potential for metal ions to enter the bloodstream.** According to the FDA application, the Ceramax does have some metal components, such as the metal shell cup, but it is primarily made of an advanced grade of ceramic. DePuy initially received PMA approval in 2010, but revisions to the product led to additional applications, according to the FDA document.
“We've seen that metal-on-metal devices are not going to be the future of hip replacements, but perhaps ceramic hip devices will be,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “We can hope, though, that the manufacturer has put more thought into patient safety with ceramic hips than it allegedly did with metal-on-metal hips.”
The Rottenstein Law Group encourages hip implant recipients to get a free brochure from its website to learn more about DePuy ASR lawsuits and to speak with a DePuy hip lawyer.
The first trials in the federal multidistrict litigation (MDL-2197, U.S. District Court for the Northern District of Ohio) are set to begin later this year, according to the New York Times.*** There are currently about 11,000 lawsuits in state and federal courts around the country, most in the MDL. In state courts, DePuy is 1-1 with regard to ASR verdicts. In Los Angeles, the plaintiff was awarded more than $8 million for his hip implant injuries (Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court). In Chicago, the jury found in favor of DePuy (Strum v. DePuy, et al., (2011-L-009352, Cook County [Ill.] Circuit Court). DePuy recalled the ASR in August 2010.
About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com